Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non–Vaccine-Targeted Infections From 24 Through 47 Months of Age
Jason M. Glanz(Kaiser Permanente), Ousseny Zerbo(Kaiser Permanente), Matthew F. Daley(Kaiser Permanente), David L. McClure(Marshfield Clinic), Holly C. Groom(Kaiser Permanente Center for Health Research), Natalie McCarthy(Centers for Disease Control and Prevention), James D. Nordin(HealthPartners), Sophia R. Newcomer(University of Montana), Komal J. Narwaney(Kaiser Permanente), Frank DeStefano(Abbott Fund), Michael L. Jackson(Kaiser Permanente Washington Health Research Institute), Bruno Lewin(Kaiser Permanente)
Cited by 53
Related Papers
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381
Risk of Anaphylaxis After Vaccination of Children and Adolescents
|PEDIATRICS|2003|321